Investigating genetic risk factors for Alzheimer's disease in diverse populations

Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative

NIH-funded research University of Miami School of Medicine · NIH-10909852

This study is looking at how our genes might play a role in Alzheimer's disease by analyzing DNA from a diverse group of people, especially those from different ethnic backgrounds, to help us better understand the disease and find new ways to diagnose and treat it.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine NIH-funded
Lab location1 site (Coral Gables, United States)
Project IDNIH-10909852 on NIH RePORTER

What this research studies

This research focuses on identifying genetic factors that contribute to Alzheimer's disease by analyzing DNA samples from a diverse group of individuals. The project includes whole exome and whole genome sequencing of thousands of participants, particularly those from underrepresented ethnic backgrounds. By examining genetic variations and their association with Alzheimer's, the study aims to enhance our understanding of the disease and improve diagnostic and treatment strategies. Participants may contribute to a larger dataset that helps uncover novel genetic markers linked to Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals of Hispanic, African, or Asian ancestry who are affected by Alzheimer's disease or related dementias.

Not a fit: Patients who do not belong to the targeted ethnic groups or who do not have Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential new treatments for Alzheimer's disease, particularly for diverse populations.

How similar studies have performed: Previous research initiatives focusing on genetic factors in Alzheimer's disease have shown promise, indicating that this approach could yield valuable insights.

Where this research is happening

Coral Gables, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.